Anavex Supports Alzheimer’s Foundation of America’s 3rd Annual Concepts in Care Educational Conference

New York, NY – September 8, 2014 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (OTCQB: AVXL), a clinical-stage biopharmaceutical company developing novel drug candidates to treat Alzheimer’s disease, other diseases of the central nervous system (CNS) and various types of cancer, today announced its corporate sponsorship of the upcoming Alzheimer’s Foundation of America’s…

Anavex to Present at Rodman & Renshaw 16th Annual Global Investment Conference

New York, NY – September 3, 2014 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (OTCQB: AVXL), a clinical-stage biopharmaceutical company developing novel drug candidates to treat Alzheimer’s disease, other diseases of the central nervous system (CNS) and various types of cancer, today announced that its President and Chief Executive Officer Christopher U. Missling,…